Literature DB >> 27171602

Exploring the genetic basis for clinical variation in neurofibromatosis type 1.

David H Gutmann1.   

Abstract

Entities:  

Keywords:  Cancer; brain tumor; cancer predisposition syndrome; germline mutation; glioma

Year:  2016        PMID： 27171602      PMCID： PMC4998178          DOI： 10.1080/14737175.2016.1189329

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  20 in total

1.  A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations.

Authors:  Saba Sharif; Meena Upadhyaya; Rosalie Ferner; Elisa Majounie; Andrew Shenton; Michael Baser; Nalin Thakker; D Gareth Evans
Journal:  J Med Genet       Date:  2011-01-28       Impact factor: 6.318

2.  NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Authors:  Joseph A Toonen; Corina Anastasaki; Laura J Smithson; Scott M Gianino; Kairong Li; Robert A Kesterson; David H Gutmann
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

3.  No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients.

Authors:  Sonja Hutter; Rosario M Piro; Sebastian M Waszak; Hildegard Kehrer-Sawatzki; Reinhard E Friedrich; Alvaro Lassaletta; Olaf Witt; Jan O Korbel; Peter Lichter; Martin U Schuhmann; Stefan M Pfister; Uri Tabori; Victor F Mautner; David T W Jones
Journal:  Hum Genet       Date:  2016-03-11       Impact factor: 4.132

4.  Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.

Authors:  Salmafatima S Abadin; Nancy L Zoellner; Melody Schaeffer; Bree Porcelli; David H Gutmann; Kimberly J Johnson
Journal:  J Pediatr       Date:  2015-05-28       Impact factor: 4.406

5.  Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12.

Authors:  Jessica C Amlin-Van Schaick; Sungjin Kim; Christina DiFabio; Min-Hyung Lee; Karl W Broman; Karlyne M Reilly
Journal:  Neuro Oncol       Date:  2012-01-10       Impact factor: 12.300

6.  Elevated risk for MPNST in NF1 microdeletion patients.

Authors:  T De Raedt; H Brems; P Wolkenstein; D Vidaud; S Pilotti; F Perrone; V Mautner; S Frahm; R Sciot; E Legius
Journal:  Am J Hum Genet       Date:  2003-03-26       Impact factor: 11.025

7.  Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Authors:  Kent A Robertson; Grzegorz Nalepa; Feng-Chun Yang; Daniel C Bowers; Chang Y Ho; Gary D Hutchins; James M Croop; Terry A Vik; Scott C Denne; Luis F Parada; Cynthia M Hingtgen; Laurence E Walsh; Menggang Yu; Kamnesh R Pradhan; Mary K Edwards-Brown; Mervyn D Cohen; James W Fletcher; Jeffrey B Travers; Karl W Staser; Melissa W Lee; Marcie R Sherman; Cynthia J Davis; Lucy C Miller; David A Ingram; D Wade Clapp
Journal:  Lancet Oncol       Date:  2012-10-23       Impact factor: 41.316

8.  Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.

Authors:  Feng-Chun Yang; David A Ingram; Shi Chen; Yuan Zhu; Jin Yuan; Xiaohong Li; Xianlin Yang; Scott Knowles; Whitney Horn; Yan Li; Shaobo Zhang; Yanzhu Yang; Saeed T Vakili; Menggang Yu; Dennis Burns; Kent Robertson; Gary Hutchins; Luis F Parada; D Wade Clapp
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

9.  Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.

Authors:  Karlyne M Reilly; Robert G Tuskan; Emily Christy; Dagan A Loisel; Jeremy Ledger; Roderick T Bronson; C Dahlem Smith; Shirley Tsang; David J Munroe; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

10.  Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner.

Authors:  Jessica C Walrath; Kristi Fox; Erika Truffer; W Gregory Alvord; Octavio A Quiñones; Karlyne M Reilly
Journal:  Mamm Genome       Date:  2009-04-04       Impact factor: 2.957
View more
  2 in total

1.  Molecular genetic evaluation of pediatric renovascular hypertension due to renal artery stenosis and abdominal aortic coarctation in neurofibromatosis type 1.

Authors:  Dawn M Coleman; Yu Wang; Min-Lee Yang; Kristina L Hunker; Isabelle Birt; Ingrid L Bergin; Jun Z Li; James C Stanley; Santhi K Ganesh
Journal:  Hum Mol Genet       Date:  2022-02-03       Impact factor: 5.121

2.  Neurofibromatosis Type 1 in Children: A Single-Center Experience.

Authors:  Ayşe Gonca Kaçar; Burcu Kılınc Oktay; Simge Çınar Özel; Süheyla Ocak; Nilay Güneş; Dilek Uludağ Alkaya; Beyhan Tüysüz; Hilmi Apak; Tülin Tiraje Celkan
Journal:  Turk Arch Pediatr       Date:  2021-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.